Coriolan Lebreton, Pierre Meeus, Catherine Genestie, Sabrina Croce, Frédéric Guyon, Carmen Llacer Moscardo, Sophie Taieb, Jean-Yves Blay, Sylvie Bonvalot, Emmanuelle Bompas, Christine Chevreau, Fabrice Lécuru, Léa Rossi, Florence Joly, Maria Rios, Loïc Chaigneau, Florence Duffaud, Patricia Pautier, Isabelle Ray-Coquard
Low-grade endometrial stromal sarcoma (LG-ESS) accounts for approximately 15% of all uterine sarcomas. Median age of patients is around 50 years and half of the patients are premenopausal. In all, 60% of cases present with FIGO stage I disease. Preoperatively radiologic findings of ESS are not specific. Pathological diagnosis remains essential. This review aimed to present the French guidelines for low grade ESS treatment within the Groupe sarcome français - Groupe d'étude des tumeurs osseuse (GSF-GETO)/NETSARC+ and tumeur maligne rare gynécologique (TMRG) networks...
March 27, 2023: Bulletin du Cancer